9 Meters Biopharma
Raleigh
About 9 Meters Biopharma
9 Meters Biopharma is a gastrointestinal platform company focusing on patients with rare disorders and unmet needs. The company's pipeline includes drug candidates for short bowel syndrome and celiac disease. 9 Meters Biopharma is led by a strong management team with a history of bringing novel therapeutics to market, and the company owns all global rights to their products, which are backed by more than 150 patents worldwide.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 1 – 10
- Total funding: $129.5M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2023)
- Ticker: nasdaq:NMTR
- Website: 9meters.com
- Phone: (919) 275-1933
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/9-meters-biopharma-63285 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.